Small New Year's resolutions could make a big difference in the severity of people allergies and asthma, according to an ...

Coughing and wheezing can leave anyone wondering whether it is asthma or bronchitis at play. Both of these respiratory issues ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

On average, 10.6% of Louisiana adults reported ever being told by a health professional that they have asthma. These parishes ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday ...

Asthma medication plays a key role in how well you control your condition. There are two main types of treatment, each geared toward a specific goal. Controller medications are the most important ...

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

Asthma is a chronic condition of the lungs that’s caused by inflammation of your airways. As a result, your airways constrict. This leads to wheezing and breathing difficulties. According to the ...